MedTrace Logo

Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer

NCT03597126 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-12-09

No results posted yet for this study

Summary

This study compared robot-assisted total mesorectal excision to treat very low rectal cancer within 2 cm from the dentate line to avoid permanent colostomy. improves the quality of life with better defecation function, urinary function and sexual function.

Conditions

Interventions

DEVICE

Robot-assisted surgery

robot-assisted intersphincteric resection for low location rectal cancer(T=1\&2)

DEVICE

Laparoscopic surgery

laparoscopic intersphincteric resection for low location rectal cancer(T=1\&2)

Sponsors & Collaborators

  • Southwest Hospital, China

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2022-06-01
Completion
2022-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597126 on ClinicalTrials.gov